盐酸莫西沙星(BAY 12-8039), 细菌 DNA 回旋酶抑制剂

CAS: 186826-86-8 货号: M408617 分子式: C21H24FN3O4.HCl 分子量: 437.89 Beilstein号: 8377447 EC号: 641-756-7
有货
级别和纯度: 10mM in DMSO
别名
莫西沙星(BAY12-8039)盐酸盐
储存条件
-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
M408617-1ml
现货 Stock Image
¥219.90
请输入您要添加的产品数量

概述

Moxifloxacin HCl是一种第四代喹诺酮类抗菌剂。An antibacterial agent that inhibits the activities of Topo II (DNA gyrase) and topoisomerase IV.

Information

Moxifloxacin (BAY12-8039) is a fourth-generation synthetic fluoroquinolone antibacterial agent.
In vitro

Moxifloxacin exerts its effects by trapping a DNA drug enzyme complex and specifically inhibiting ATP-dependent enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. Moxifloxacin shows in-vitro potency against M. tuberculosis H37Rv with MIC of 0.177 μg/mL. Moxifloxacin has broad Grampositive and Gram-negative activity. Moxifloxacin shows in vitro and clinical efficacy against Staphylococcus aureus, Streptococcus pneumoniae, Str. pyogenes, Haemophilus influenzae, H. parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydia pneumoniae and Mycoplasma pneumoniae. Moxifloxacin has activity against mycobacteria in addition to M. tuberculosis; Moxifloxacin is more active against M. kansasii than M. avium complex: specifically MIC90 for M. avium > M. intracellulare > M. kansasii at 4, 2 and 2 μg/mL, respectively. MIC90 for M. chelonae > M. fortuitum at 16 and 0.5 μg/mL, respectively.

In vivo

Moxifloxacin combined with RIF/pyrazinamide (PZA) reduces treatment time by up to 2 months compared to regimens with isoniazid (INH)/RIF/PZA in a mouse model designed to mimic human disease. Similar results with a stable cure are reached after 4 months in mice treated twice weekly with RIF/Moxifloxacin/PZA compared to cure in 6 months when daily treated with RIF/INH/PZA. 100 mg/kg Moxifloxacin in mice gives activity comparable to INH; increased dose in mice to 400 mg/kg Moxifloxacin daily results in spleen CFU counts lower than for INH 25 mg/kg although the differences are not statistically significant. AUC/MIC ratio correlates best with in-vivo efficacy for the fluoroquinolones in a mouse model of tuberculosis.
Cell Data

cell lines:MACS-selected CD34+ cells

Concentrations:

Incubation Time:

Powder Purity:≥99%

规格

别名
莫西沙星(BAY12-8039)盐酸盐
英文别名
1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
规格或纯度
10mM in DMSO
英文名称
Moxifloxacin HCl(BAY 12-8039)
生化机理
莫西沙星(BAY12-8039)是第四代合成氟喹诺酮类抗菌药。
储存条件
-80℃储存
运输条件
特低温运输
作用类型
抑制剂
作用机制
细菌 DNA 回旋酶抑制剂
名称和识别符
EC号
641-756-7
分子类型
小分子
Isomeric SMILES
COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl
关联CAS
分子量
437.89
Beilstein号
8377447
Reaxy-Rn
11191843
Reaxys-RN link address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=11191843&ln=

高级数据

化学和物理性质
溶解性
Solubility (25°C) In vitro DMSO: 19 mg/mL (81.08 mM); Water: Insoluble; Ethanol: Insoluble;
熔点
323.9-325°C
安全和危险性(GHS)
信号词
警告
危险声明

H227: 可燃液体

预防措施声明

P210: 远离热源,热表面,火花,明火和其他点火源。 - 禁止抽烟。

P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。

P370+P378: 火灾时:使用干砂、干粉或抗醇泡沫灭火。

P403: 存放在通风良好的地方。

P501: 将内容物/容器送到批准的废物处理厂处理

RTECS
VB1983750
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到1个结果

批号(Lot Number) 证书类型 货号
L2230019L2230019 分析证书 M408617
技术文档和文章
此产品的引用文献
溶液计算器

常见问题

本产品应如何储存?
请于?80 °C条件下保存。需超低温保存以维持规定的有效期。
本产品如何运输?
本产品采用干冰配冷袋冷冻运输。收货后请立即拆包,并按上述储存条件保存;处理干冰时请戴隔热手套并保持通风。
本产品的 CAS 号、分子式和分子量是多少?
本产品的 CAS 号为 186826-86-8,分子式为 C21H25ClFN3O4,分子量为 437.89 g/mol。
如何获取批次专用COA?
每个订单都会随附分析证书(COA),您也可以从账户订单历史中下载。如需订购前的COA,请联系您的客户代表,或使用PDP上的"申请COA"按钮——我们将提供代表性批次的COA。